English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Thromboangitis obliterans (TAO), also known as Buerger’s disease (BD), is a non-atherosclerotic, segmental, inflammatory, episodic, non-destructive, thrombotic, and occlusive disease of unknown origin compromising small to medium-sized distal arteries, veins, and nerves (1). Intravenous iloprost (2), intermittent pneumatic compression (3), bosentan (4), and cilostazol (5) are used or experimental medical therapies for TAO, for all that smoking cessation is the sole definitive therapy. Surgical revascularization is usually not preferred because of high involvement of distal segments of vessels. Endovascular revascularization could be an option for patients with bad distal vasculature. Case Report

Successful sequential drug eluting balloon angioplasty to chronic total occluded popliteal artery in a patient with thromboangitis obliterans by PCR